Antidepressant Suicidality Needs Interim Risk Management, FDAer Maintains
FDA should establish an interim risk management plan to discourage pediatric antidepressant use, FDA epidemiologist Andrew Mosholder, MD, maintained in an Aug. 16 memo
FDA should establish an interim risk management plan to discourage pediatric antidepressant use, FDA epidemiologist Andrew Mosholder, MD, maintained in an Aug. 16 memo